Antigen-specific T cell balance reveals Why patients with atopic dermatitis fail to achieve immune tolerance

Copyright © 2023 Elsevier Inc. All rights reserved.

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 252(2023) vom: 25. Juli, Seite 109649
1. Verfasser: Inaba, Masako (VerfasserIn)
Weitere Verfasser: Fukushima, Hiroko, Hara, Monami, Hosaka, Sho, Fujiyama, Satoshi, Maruo, Kazushi, Nomura, Toshifumi, Okiyama, Naoko, Takada, Hidetoshi
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2023
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Journal Article Research Support, Non-U.S. Gov't Antigen specificity Atopic dermatitis CD137 CD154 Mite antigen Regulatory T cell Antigens Cytokines
Beschreibung
Zusammenfassung:Copyright © 2023 Elsevier Inc. All rights reserved.
The number of regulatory T cells (Tregs) and how they behave in the pathogenesis of atopic dermatitis (AD) are still controversial. We identified and quantified Tregs, mite-specific Tregs, and mite-specific effector T cells (Teffs) in patients with AD and healthy controls (HCs). We collected peripheral blood and analyzed the cells using flow cytometry after stimulation with mite antigens. Mite-specific Tregs and mite-specific Teffs were recognized by the expression of CD137 and CD154, respectively. Patients with AD had more Tregs than HCs; however, when focusing on a single antigen, the ratio of mite-specific Tregs/Teffs was lower in patients with AD than in HCs. Furthermore, the mite-specific Teffs in patients with AD were more likely to produce proinflammatory cytokines interleukin (IL)-4 and IL-13. This Teff-dominant imbalance is thought to be the cause of development of atopic status in patients with AD without immune tolerance
Beschreibung:Date Completed 15.06.2023
Date Revised 21.06.2023
published: Print-Electronic
Citation Status MEDLINE
ISSN:1521-7035
DOI:10.1016/j.clim.2023.109649